Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2000
05/11/2000CA2317117A1 Ldl related protein and uses thereof
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/10/2000EP0999219A2 Novel heparin binding peptides
05/10/2000EP0998933A1 Process for producing pharmaceutical compositions containing diphosphonates for oral administration
05/10/2000EP0998932A1 Solid pharmaceutical dosage form containing diphosphonates or their salts and method for its production
05/10/2000EP0998556A2 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
05/10/2000EP0998477A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
05/10/2000EP0998471A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
05/10/2000EP0998465A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
05/10/2000EP0998464A1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
05/10/2000EP0998455A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain
05/10/2000EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998296A1 Products from cypress and all relative coniferous trees and their pharmaceutical uses
05/10/2000EP0998293A1 Cytokine related treatments of disease
05/10/2000EP0998292A2 Method for inhibiting bone resorption
05/10/2000EP0998291A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
05/10/2000EP0998284A1 Composition comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000EP0820428B1 Terminal carboxy or tetrazole groups containing dialkyl ethers
05/10/2000EP0800503B1 Novel trienoic retinoid compounds and methods
05/10/2000EP0671922B1 Fluidized intestinal submucosa and its use as an injectable tissue graft
05/10/2000EP0602172B1 A method for treatment of patients with chronic liver disease
05/10/2000EP0563301B1 Cosmetic Process of Reducing the Rate of Mammalian Hair Growth
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252797A Kodaistatins A, B, C and D, a process for their production and their use
05/10/2000CN1252792A Process and intermediates for the preparation of 4'-trifluoromethyl-bipheyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
05/10/2000CN1252791A Arylsecochladiene derivatives
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252716A Inhibitor of leaderless protein export
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252695A Process for preparing a nutritional supplement
05/10/2000CN1252298A Hypoglycemic pharmaceutical and hypoglycemic food and the extraction method of its effective component
05/10/2000CN1252273A Preparation and application of seleno-methionine chrome yellow urea as hypoglycemic
05/10/2000CN1252238A Stable powder tomato red agent preparation containing crystallinity large than 20% tomato red agent
05/09/2000US6060496 Long lasting at small dosages
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060492 Side effect reduction
05/09/2000US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof
05/09/2000US6060468 N-substituted azaheterocyclic compounds
05/09/2000US6060446 Protein and carnosine, glutathione, and/or cyclo-histidine-proline
05/09/2000US6060050 Carrier acts as a growth or maintenance medium for microorganisms in the large bowel or other regions of the gastrointestinal tract.
05/09/2000CA2151560C Insulin analog formulations
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/09/2000CA2030838C Preparations containing l-carnitine
05/09/2000CA1340985C Peptide derivatives
05/04/2000WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024785A1 Substance for reduction of cholesterol as well as lipids content
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024712A1 Vitamin d3 derivatives and remedies for inflammatory respiratory diseases containing the same
05/04/2000WO2000024437A2 Textured and porous silicone rubber
05/04/2000WO2000024422A1 Process for producing glycolytic metabolism regulators
05/04/2000WO2000024418A1 Prevention of muscle mass loss with leptin receptor ligands
05/04/2000WO2000024416A1 Remedies for bone metabolic errors
05/04/2000WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway
05/04/2000WO2000024360A2 Preparation and use of solidified oils
05/04/2000WO2000024272A1 Sweetener
05/04/2000WO2000012741A3 Inducible expression system
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO1999043672A9 Inhibitors of phospholipase a2
05/04/2000DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348529A1 Conductance of improperly folded proteins through the secretory pathway
05/04/2000CA2348235A1 Vitamin d3 derivatives and treating agent for inflammatory respiratory disease using same
05/04/2000CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000CA2347967A1 Substance for reduction of cholesterol as well as lipids content
05/04/2000CA2347107A1 Bone-pathobolism treating agent
05/04/2000CA2346820A1 Preparation and use of solidified oils
05/04/2000CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/03/2000EP0997477A2 MHC complexes and uses thereof
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0997151A2 Method for administering insulinotropic peptides
05/03/2000EP0997149A1 Compositions comprising guggul extract and phosphate salts
05/03/2000EP0996732A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
05/03/2000EP0996630A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
05/03/2000EP0996508A1 Film coatings and film coating compositions based on dextrin
05/03/2000EP0996466A2 Novel composition comprising an ssri and a beta-blocker
05/03/2000EP0996459A1 Use of exendins and agonists thereof for the reduction of food intake
05/03/2000EP0996454A1 Polyallylamine polymers for treating hypercholesterolemia
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0996444A1 Treatment of diabetes with thiazolidinedione and metformin
05/03/2000EP0996443A1 Certain diarylimidazole derivatives; a new class of npy specific ligands
05/03/2000EP0996431A1 Synergistic compositions of lycopene and vitamin e for the prevention of ldl oxidation
05/03/2000EP0719767B1 Succinamic acid compound, process for producing the same, and use thereof
05/03/2000EP0563096B1 Novel methylenebisphosphonic acid derivatives
05/03/2000EP0559884B1 Viral recombinant vectors for expression in muscle cells
05/03/2000CN1252101A Component of bromelain
05/03/2000CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
05/03/2000CN1252068A 3-piperidyl-4-oxoquinazoline derivatives and medicinal compositions containing same
05/03/2000CN1252057A 2-amino substituted pyridines for treating arteriosclerosis and hyperlipoproteinaemia
05/03/2000CN1252053A Cetp activity inhibitors
05/03/2000CN1252000A Pharmaceutical compositions having appetite suppressant activity
1 ... 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 ... 1298